医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

2nd Murata Hackathon to Be Held in Israel:Seeking New Ideas in IoT

2016年09月05日 PM03:00
このエントリーをはてなブックマークに追加


 

HOOFDDORP, The Netherlands

Murata Electronics Europe B.V.:

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160904005009/en/

Last year's hackathon (Photo: Business Wire)

Last year’s hackathon (Photo: Business Wire)

Overview

Murata Electronics Europe B.V. is partnering with Samurai Incubate Inc. (Headquarters: Shinagawa, Tokyo; CEO: Kentaro Sakakibara) to host the 2nd Murata Hackathon, an event that seeks new business ideas in IoT, from September 14-15 in Israel.

*What is a “hackathon”?
A hackathon, coined by combining the words “hack” and “marathon,” is an event in which engineers come together to compete in teams and give shape to ideas. Participants write programs and develop applications over the course of several days.

Summary

With the world of the Internet of Things or “IoT” expanding at a rapid pace, there is demand for the birth of unprecedented and innovative products. Murata is therefore targeting the creation of new business in IoT and following last year’s event, it will host the 2nd Murata Hackathon in Israel. The event is aimed at developing new applications by integrating Murata’s state-of-the-art parts, especially sensors and communication modules, with original ideas from Israel, a country known for its software development expertise.

 

Details of Hackathon

Name   2nd Murata Hackathon in Israel
Organizer/Partner

Organizer: Murata Electronics Europe B.V.
Partner: Samurai Incubate Inc.

Dates September 14-15, 2016
Location Tel Aviv, Israel
Conditions for participation Entry in teams (2-5 members)
Number of teams accepted 15 teams
Schedule

Entries open: June 2, 2016
Entry deadline: August 31, 2016
Hackathon: September 14-15, 2016

URL  

https://docs.google.com/forms/d/e/1FAIpQLSfNBu_w6ifRHEDwGRHMmZuZk0EGeN9SgsBy57PYYkSN38IsQg/viewform

 

Eleven teams participated in last year’s 1st Murata Hackathon. The winner, Israeli startup The Elegant Monkeys (TEM), has entered into an agreement with Murata to pursue joint development in the healthcare sector.

The Elegant Monkeys comment on winning the 1st Murata Hackathon

The Elegant Monkeys is excited to start a highly ambitious and strategic cooperation with Murata, made possible as a result of winning their 1st Israeli Hackathon last year. We believe that the combination of Japanese top-quality hardware innovation alongside the Israeli software and algorithm expertise, will lead to a new industry standard of products. Although we cannot elaborate at this time, this joint venture is a big step for the Israeli-Japanese collaboration towards global technological advancements.

About The Elegant Monkeys

TEM is an Israeli-based startup company, specializing in Software, Mobile, IoT (Internet of Things) and Healthcare Technologies. TEM is pursuing the vision of translating human emotions to digital signals in order to improve quality-of-life for the modern society through technological innovations. For more information, visit TEM’s website at https://www.elegantmonkeys.com/

About Samurai Incubate Inc.

As one of Japan’s leading incubators, Samurai Incubate Inc. has launched many proactive efforts under its mission of changing the world through “Go Action! Go Change!,” including its Samurai Startup Island (Tokyo) and Samurai House (Israel) co-working spaces for incubation, Samurai Venture Summit events to support entrepreneurs (held in Japan and North America along with ASEAN, Israel, and more), and an investment fund. For details, visit http://www.samurai-incubate.asia/

View source version on businesswire.com: http://www.businesswire.com/news/home/20160904005009/en/

CONTACT

Murata Manufacturing Co., Ltd.
Junko Matsumura, +81-75-955-6786
Corporate
Communication Office
pesec_mmc@murata.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高